“Postoperative Radiotherapy for Patients With Completely Resected Pathological Stage IIIA-N2 Non-Small Cell Lung Cancer: A Preferential Benefit for Squamous Cell Carcinoma”. Radiology and Oncology, vol. 55, no. 1, Feb. 2021, pp. 66-76, https://www.ojstest.computing.si/index.php/ro/article/view/3516.